Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Settlement topic
No spam. Unsubscribe anytime.
Select Board authorizes participation forms for opioid settlements including Sackler and secondary manufacturers
Summary
Templeton’s Select Board authorized the chair to sign participation documents for opioid litigation settlements with the Sackler-related Purdue settlement and several secondary manufacturers, expanding the town’s participation in national settlements.
The Templeton Select Board on Sept. 10 authorized the chair to sign participation forms to join national opioid litigation settlements, including agreements tied to Purdue Pharma (Sackler-related) and a set of secondary manufacturers. The board amended an initial motion to add a set of secondary manufacturers and voted to approve the broader participation.
Why it matters: Participation in national settlements can make Templeton eligible for state-administered settlement funds for opioid-related abatement and local programs. The board’s action opens the town to share distributions from agreed settlements and signals municipal coordination with national settlement processes.
A Select Board member initially moved to authorize the chair to sign DocuSign documents related to settlements for Purdue/Sackler and Sandoz. After discussion prompted by a board member’s question about other manufacturers, the motion was amended on the floor to authorize participation documents for additional secondary manufacturers (Alvogen, Apotex, Hikma, Mylan, Sun, and one identified as "Rydus" in the meeting packet). The amended motion passed with the board’s unanimous consent.
The board did not discuss specific distribution amounts at the meeting. The chair was authorized to execute the necessary participation forms; staff will complete the administrative steps required for the town to be included in the listed national settlements.
